Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

The progression of Parkinson's disease often requires a change of therapy. An expert explains when this should be done and ...

People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...

This report offers insights into recent health news, encompassing advancements in Parkinson's and cancer treatments, ...

Tavapadon met the primary endpoint in the pivotal Phase 3 TEMPO-2 flexible-dose monotherapy trial, demonstrating a statistically significant improvement from baseline in the MDS-UPDRS Parts II and III ...

Participants completed self-report questionnaires (Geriatric Depression Scale, Parkinson's Anxiety Scale, Parkinson's Disease Questionnaire-39 ... understanding of EMST and TS to determine if they are ...

We think UCB is in good financial health, with solid earnings and cash flow generation. UCB has deleveraged over the years, and it ended 2023 with about EUR 2.2 billion in net debt on its balance ...

I’ve described Parkinson’s as an “unforgiving” disease and a “slow crawl into the brambles.” Kathy is the love of my life.

Luckily, there are several non-surgical treatments available on the market to help combat these signs of ageing, as well as prevent further wrinkles and sagging from occurring. We spoke to six ...

There is currently no cure for dementia. However, there are treatments and support services that can help someone with the condition. These include drug and non-drug treatments, support, activities, ...

Therefore, it's important that health professionals conduct a detailed patient history, including history of exposure to ticks when assessing individuals with signs or symptoms suggestive of Lyme ...

Credit: Stock-Asso/Shutterstock. Arrowhead Pharmaceuticals has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics to develop treatments for rare genetic diseases.